KCTD15 Human (-)-demecolcine decreases expression EXP 6480464 Demecolcine results in decreased expression of KCTD15 mRNA CTD PMID:23649840 KCTD15 Human 1-nitropyrene increases expression EXP 6480464 1-nitropyrene results in increased expression of KCTD15 mRNA CTD PMID:19041380 KCTD15 Human 17alpha-ethynylestradiol increases expression ISO Kctd15 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of KCTD15 mRNA CTD PMID:17942748 KCTD15 Human 17alpha-ethynylestradiol multiple interactions ISO Kctd15 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KCTD15 mRNA CTD PMID:17942748 KCTD15 Human 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Kctd15 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 KCTD15 Human 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Kctd15 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 KCTD15 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Kctd15 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of KCTD15 mRNA CTD PMID:19933214 KCTD15 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Kctd15 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of KCTD15 mRNA CTD PMID:21570461 KCTD15 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Kctd15 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KCTD15 mRNA CTD PMID:17942748 KCTD15 Human acetamide increases expression ISO Kctd15 (Rattus norvegicus) 6480464 acetamide results in increased expression of KCTD15 mRNA CTD PMID:31881176 KCTD15 Human aflatoxin B1 decreases methylation EXP 6480464 Aflatoxin B1 results in decreased methylation of KCTD15 intron CTD PMID:30157460 KCTD15 Human Aflatoxin B2 alpha increases methylation EXP 6480464 aflatoxin B2 results in increased methylation of KCTD15 3' UTR CTD PMID:30157460 KCTD15 Human all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of KCTD15 mRNA CTD PMID:33167477 KCTD15 Human alpha-Zearalanol multiple interactions ISO Kctd15 (Rattus norvegicus) 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KCTD15 mRNA CTD PMID:35163327 KCTD15 Human antirheumatic drug increases expression EXP 6480464 Antirheumatic Agents results in increased expression of KCTD15 mRNA CTD PMID:24449571 KCTD15 Human aristolochic acid A decreases expression EXP 6480464 aristolochic acid I results in decreased expression of KCTD15 mRNA CTD PMID:33212167 KCTD15 Human arsane affects methylation EXP 6480464 Arsenic affects the methylation of KCTD15 gene CTD PMID:25304211 KCTD15 Human arsenic atom affects methylation EXP 6480464 Arsenic affects the methylation of KCTD15 gene CTD PMID:25304211 KCTD15 Human atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of KCTD15 mRNA CTD PMID:22378314 KCTD15 Human benzo[a]pyrene increases mutagenesis EXP 6480464 Benzo(a)pyrene results in increased mutagenesis of KCTD15 gene CTD PMID:25435355 KCTD15 Human benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of KCTD15 intron CTD PMID:30157460 KCTD15 Human benzo[a]pyrene multiple interactions ISO Kctd15 (Mus musculus) 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of KCTD15 mRNA] CTD PMID:22228805 KCTD15 Human benzo[a]pyrene decreases expression ISO Kctd15 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of KCTD15 mRNA CTD PMID:22228805 KCTD15 Human bisphenol A affects expression ISO Kctd15 (Rattus norvegicus) 6480464 bisphenol A affects the expression of KCTD15 mRNA CTD PMID:25181051 KCTD15 Human bisphenol A decreases expression ISO Kctd15 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of KCTD15 mRNA CTD PMID:33296240 KCTD15 Human bisphenol A increases expression ISO Kctd15 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of KCTD15 mRNA CTD PMID:30816183 and PMID:34947998 KCTD15 Human bisphenol A decreases expression ISO Kctd15 (Mus musculus) 6480464 bisphenol A results in decreased expression of KCTD15 mRNA CTD PMID:25594700 KCTD15 Human bisphenol F multiple interactions EXP 6480464 [bisphenol F co-treated with Fulvestrant] results in decreased methylation of KCTD15 gene CTD PMID:31601247 KCTD15 Human bromobenzene increases expression ISO Kctd15 (Rattus norvegicus) 6480464 bromobenzene results in increased expression of KCTD15 mRNA CTD PMID:32479839 KCTD15 Human butanal decreases expression EXP 6480464 butyraldehyde results in decreased expression of KCTD15 mRNA CTD PMID:26079696 KCTD15 Human carbon nanotube increases expression ISO Kctd15 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 KCTD15 Human chlordecone increases expression ISO Kctd15 (Mus musculus) 6480464 Chlordecone results in increased expression of KCTD15 mRNA CTD PMID:33711761 KCTD15 Human chlorpyrifos increases expression ISO Kctd15 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of KCTD15 mRNA CTD PMID:37019170 KCTD15 Human choline multiple interactions ISO Kctd15 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of KCTD15 gene CTD PMID:20938992 KCTD15 Human chrysene increases expression ISO Kctd15 (Mus musculus) 6480464 chrysene results in increased expression of KCTD15 mRNA CTD PMID:26377693 KCTD15 Human cisplatin decreases expression ISO Kctd15 (Rattus norvegicus) 6480464 Cisplatin results in decreased expression of KCTD15 mRNA CTD PMID:22023808 KCTD15 Human cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of KCTD15 mRNA CTD PMID:27392435 KCTD15 Human copper atom increases expression ISO Kctd15 (Rattus norvegicus) 6480464 Copper results in increased expression of KCTD15 mRNA CTD PMID:30556269 KCTD15 Human copper(0) increases expression ISO Kctd15 (Rattus norvegicus) 6480464 Copper results in increased expression of KCTD15 mRNA CTD PMID:30556269 KCTD15 Human cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of KCTD15 mRNA CTD PMID:20106945 KCTD15 Human diazinon increases methylation EXP 6480464 Diazinon results in increased methylation of KCTD15 gene CTD PMID:22964155 KCTD15 Human dicrotophos increases expression EXP 6480464 dicrotophos results in increased expression of KCTD15 mRNA CTD PMID:28302478 KCTD15 Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCTD15 mRNA CTD PMID:27188386 KCTD15 Human doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of KCTD15 mRNA CTD PMID:29803840 KCTD15 Human entinostat decreases expression EXP 6480464 entinostat results in decreased expression of KCTD15 mRNA CTD PMID:27188386 KCTD15 Human enzyme inhibitor multiple interactions EXP 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of KCTD15 protein CTD PMID:23301498 KCTD15 Human ethyl methanesulfonate decreases expression EXP 6480464 Ethyl Methanesulfonate results in decreased expression of KCTD15 mRNA CTD PMID:23649840 KCTD15 Human folic acid multiple interactions ISO Kctd15 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of KCTD15 gene CTD PMID:20938992 KCTD15 Human formaldehyde decreases expression EXP 6480464 Formaldehyde results in decreased expression of KCTD15 mRNA CTD PMID:23649840 KCTD15 Human FR900359 increases phosphorylation EXP 6480464 FR900359 results in increased phosphorylation of KCTD15 protein CTD PMID:37730182 KCTD15 Human fulvestrant multiple interactions EXP 6480464 [bisphenol F co-treated with Fulvestrant] results in decreased methylation of KCTD15 gene CTD PMID:31601247 KCTD15 Human furan increases expression ISO Kctd15 (Rattus norvegicus) 6480464 furan results in increased expression of KCTD15 mRNA CTD PMID:27387713 KCTD15 Human genistein increases expression ISO Kctd15 (Mus musculus) 6480464 Genistein results in increased expression of KCTD15 mRNA CTD PMID:32186404 KCTD15 Human gentamycin decreases expression ISO Kctd15 (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of KCTD15 mRNA CTD PMID:33387578 KCTD15 Human L-methionine multiple interactions ISO Kctd15 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of KCTD15 gene CTD PMID:20938992 KCTD15 Human methoxychlor affects methylation ISO Kctd15 (Rattus norvegicus) 6480464 Methoxychlor affects the methylation of KCTD15 gene CTD PMID:35440735 KCTD15 Human methyl methanesulfonate decreases expression EXP 6480464 Methyl Methanesulfonate results in decreased expression of KCTD15 mRNA CTD PMID:23649840 KCTD15 Human N,N-diethyl-m-toluamide multiple interactions ISO Kctd15 (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in decreased methylation of KCTD15 gene CTD PMID:33148267 KCTD15 Human nickel dichloride affects expression ISO Kctd15 (Rattus norvegicus) 6480464 nickel chloride affects the expression of KCTD15 mRNA CTD PMID:22110744 KCTD15 Human nickel sulfate decreases expression EXP 6480464 nickel sulfate results in decreased expression of KCTD15 mRNA CTD PMID:16780908 KCTD15 Human O-methyleugenol increases expression EXP 6480464 methyleugenol results in increased expression of KCTD15 mRNA CTD PMID:32234424 KCTD15 Human oxaliplatin increases expression ISO Kctd15 (Rattus norvegicus) 6480464 oxaliplatin results in increased expression of KCTD15 mRNA CTD PMID:25729387 KCTD15 Human oxaliplatin multiple interactions ISO Kctd15 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of KCTD15 mRNA CTD PMID:25729387 KCTD15 Human paracetamol affects expression ISO Kctd15 (Mus musculus) 6480464 Acetaminophen affects the expression of KCTD15 mRNA CTD PMID:17562736 KCTD15 Human paracetamol decreases expression ISO Kctd15 (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of KCTD15 mRNA CTD PMID:33387578 KCTD15 Human PCB138 multiple interactions ISO Kctd15 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 KCTD15 Human pentachlorophenol increases expression ISO Kctd15 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of KCTD15 mRNA CTD PMID:23892564 KCTD15 Human pentanal decreases expression EXP 6480464 pentanal results in decreased expression of KCTD15 mRNA CTD PMID:26079696 KCTD15 Human perfluorohexanesulfonic acid decreases expression ISO Kctd15 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in decreased expression of KCTD15 mRNA CTD PMID:37995155 KCTD15 Human perfluorononanoic acid increases expression EXP 6480464 perfluoro-n-nonanoic acid results in increased expression of KCTD15 mRNA CTD PMID:32588087 KCTD15 Human perfluorooctanoic acid multiple interactions ISO Kctd15 (Rattus norvegicus) 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KCTD15 mRNA CTD PMID:35163327 KCTD15 Human permethrin multiple interactions ISO Kctd15 (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in decreased methylation of KCTD15 gene CTD PMID:33148267 KCTD15 Human potassium chromate increases expression EXP 6480464 potassium chromate(VI) results in increased expression of KCTD15 mRNA CTD PMID:22714537 KCTD15 Human propanal decreases expression EXP 6480464 propionaldehyde results in decreased expression of KCTD15 mRNA CTD PMID:26079696 KCTD15 Human propionic acid decreases expression EXP 6480464 propionic acid results in decreased expression of KCTD15 mRNA CTD PMID:31526819 KCTD15 Human SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCTD15 mRNA CTD PMID:27188386 KCTD15 Human silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of KCTD15 mRNA CTD PMID:25351596 KCTD15 Human sodium dichromate affects expression ISO Kctd15 (Rattus norvegicus) 6480464 sodium bichromate affects the expression of KCTD15 mRNA CTD PMID:22110744 KCTD15 Human sunitinib increases expression EXP 6480464 Sunitinib results in increased expression of KCTD15 mRNA CTD PMID:31533062 KCTD15 Human temozolomide increases expression EXP 6480464 Temozolomide results in increased expression of KCTD15 mRNA CTD PMID:31758290 KCTD15 Human tetrachloromethane affects expression ISO Kctd15 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of KCTD15 mRNA CTD PMID:17484886 KCTD15 Human tetrachloromethane increases expression ISO Kctd15 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of KCTD15 mRNA CTD PMID:31919559 KCTD15 Human tetrachloromethane increases expression ISO Kctd15 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in increased expression of KCTD15 mRNA CTD PMID:31150632 KCTD15 Human thioacetamide increases expression ISO Kctd15 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of KCTD15 mRNA CTD PMID:34492290 KCTD15 Human topotecan multiple interactions ISO Kctd15 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of KCTD15 mRNA CTD PMID:25729387 KCTD15 Human topotecan increases expression ISO Kctd15 (Rattus norvegicus) 6480464 Topotecan results in increased expression of KCTD15 mRNA CTD PMID:25729387 KCTD15 Human trichostatin A decreases expression EXP 6480464 trichostatin A results in decreased expression of KCTD15 mRNA CTD PMID:24935251 KCTD15 Human tunicamycin increases expression ISO Kctd15 (Mus musculus) 6480464 Tunicamycin results in increased expression of KCTD15 mRNA CTD PMID:17127020 KCTD15 Human tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of KCTD15 mRNA CTD PMID:29453283 KCTD15 Human urethane decreases expression EXP 6480464 Urethane results in decreased expression of KCTD15 mRNA CTD PMID:28818685 KCTD15 Human valproic acid decreases expression ISO Kctd15 (Mus musculus) 6480464 Valproic Acid results in decreased expression of KCTD15 mRNA CTD PMID:20546886 and PMID:21427059 KCTD15 Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of KCTD15 mRNA CTD PMID:25979313 KCTD15 Human valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of KCTD15 mRNA CTD PMID:19101580 more ... KCTD15 Human valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCTD15 mRNA CTD PMID:27188386 KCTD15 Human vorinostat decreases expression EXP 6480464 vorinostat results in decreased expression of KCTD15 mRNA CTD PMID:27188386
